Oncology

  1. Tecentriq (atezolizumab)
    Tecentriq (atezolizumab)
    by Roche Registration Limited
    for Urothelial Carcinoma, Lung Cancer
    €4,331.25
  2. Zejula (niraparib)
    Zejula (niraparib)
    by Tesaro UK Limited
    for Gynaecological Cancer
    €7,647.20
View as Grid List

Items 37-38 of 38

Page
per page
Set Descending Direction